基础医学与临床 ›› 2015, Vol. 35 ›› Issue (12): 1648-1652.

• 研究论文 • 上一篇    下一篇

HBV感染患者循环microRNA-24的表达与作用机制

梁宏1,朱永昌1,陆若飞2   

  1. 1. 江苏省启东市第三人民医院
    2. 江苏省启东市人民医院
  • 收稿日期:2015-07-23 修回日期:2015-10-26 出版日期:2015-12-05 发布日期:2015-12-04
  • 通讯作者: 陆若飞 E-mail:lrf720508@163.com

Expression of circulating microRNA-24 in patients with HBV infection and relative mechanisms

  • Received:2015-07-23 Revised:2015-10-26 Online:2015-12-05 Published:2015-12-04

摘要: 目的 检测乙型肝炎病毒(HBV)感染患者血清中循环microRNA-24(miR-24)表达的变化,并探讨miR-24与HBV感染的关系及作用机制。方法 收集45例HBV感染者和22例健康正常对照者的一般临床资料和血清样本,用实时定量PCR(qRT-PCR)检测两者血清中miR-24的表达;用ELISA法检测乙肝表面抗原(HBsAg)和乙肝E抗原(HBeAg)的含量;在HepG2.2.15细胞中转染miR-24模拟物(mimic)48 h,qRT-PCR检测HepG2.2.15细胞中miR-24表达;再用ELISA法检测HBsAg和HBeAg含量,并用qRT-PCR检测细胞中前C基因HBV RNA表达。结果 HBV感染组血清中循环miR-24的表达水平均显著低于对照组(p<0.01)。HepG2.2.15细胞中HBsAg和HBeAg含量均显著高于HepG2细胞(p<0.01)。在HepG2.2.15细胞中转染miR-24 mimic后,miR-24的表达显著增高(p<0.01);miR-24显著抑制了细胞中HBsAg和HBeAg(p<0.01)分泌;并抑制了细胞中前C基因HBV RNA表达(p<0.05)。结论 miR-24在HBV感染患者体内表达下调,增强miR-24表达的治疗策略有望使HBV感染患者受益。

关键词: microRNA-24, 乙肝病毒, 乙肝表面抗原, 乙肝E抗原

Abstract: Objective To detect the expression of circulating microRNA-24 (miR-24) in patients with hepatitis B virus (HBV) infection, and investigate the relationship between miR-24 expression and HBV infection and the mechanisms. Methods Clinical information and laboratory date from 45 patients with HBV infection and 22 health normal controls were collected. qRT-PCR was used to detect the expression of miR-24 in patients with HBV infection and health normal controls. ELISA was used to detect the contents of hepatitis B surface antigen (HBsAg) and hepatitis B E antigen (HBeAg). After the HepG2.2.15 cell was transfected with miR-24 mimic for 48 hours, the expression of miR-24 was analyzed by qRT-PCR. ELISA was used again to investigate the contents of HBsAg and HBeAg. And qRT-PCR was used to detect the expression of Pre-Core HBV RNA. Results The expression of circulating miR-24 in patients with HBV infection was significantly lower than that of in health normal controls (p<0.01). The contents of HBsAg and HBeAg in HepG2.2.15 were significantly higher than those of in HepG2. The expression of miR-24 was higher in HepG2.2.15 after transfected with miR-24 mimic for 48 hours. MiR-24 decreased the contents of HBsAg and HBeAg (p<0.01), and inhibited the expression of Pre-Core HBV RNA (p<0.05) in HepG2.2.15 cell, respectively. Conclusion The expression of miR-24 in patients with HBV infection was down regulated. Treatment based on the enhanced expression of miR-24 may be a promising strategy for HBV infection.

Key words: microRNA-24, hepatitis B virus (HBV), hepatitis B surface antigen (HBsAg), hepatitis B E antigen (HBeAg)